Manipal Health Enterprises Posts Record INR3,400 Crores Revenue in Q2 FY27 with 37% Volume Growth
EBITDA rises 30% to INR882 crores; Digital health revenue contributes 23% in H1 FY27; Sahyadri Hospitals EBITDA margin improves to 19.5% in Q2
Manipal Health Enterprises Limited posted its best-ever quarter in Q2 FY27 with revenues reaching INR3,400 crores, marking a 37% increase year-over-year. The company reported a 30% rise in EBITDA to INR882 crores and an average occupancy increase to 70%, supported by digital revenue contributing 23% of total revenue in H1 FY27. Sahyadri Hospitals reported a 13% sequential revenue growth in Q2 with EBITDA margin improving to 19.5%.
Manipal Health Enterprises Limited
Earnings Call Transcript
Manipal Health Enterprises Limited achieved its highest quarterly performance in Q2 FY27, recording revenues of INR3,400 crores, a 37% increase year-on-year. The company’s EBITDA grew by 30% to INR882 crores, supported by increased inpatient and outpatient volumes and higher occupancy rates.
Healthcare volumes drove growth with inpatient volumes up 35% and outpatient volumes up 27% year-on-year. Average occupancy improved from 65% in Q1 FY27 to 70% in Q2 FY27, maintaining an industry-leading average length of stay of 2.8 days.
Revenue per occupied bed per day excluding Sahyadri Hospitals was approximately INR77,000, marking over 8% growth year-on-year, while the network-wide average stood at INR70,600.
In the first half of FY27, Manipal Health reported revenue of INR6,490 crores (a 38% increase) and EBITDA of INR1,631 crores (up 28%), with a PAT of INR639 crores representing a 10% margin. Digital revenue accounted for 23% of total revenue in H1 FY27, driven by e-pharmacy (34,000 orders), telehealth solutions (38,000 virtual consultations), and AI-enabled chatbot interactions (24,000).
Centers of excellence specialties contributed 64.2% of revenue in H1 FY27, growing by 43%, led by oncology, neurology, and orthopedics. Investments included deploying the Da Vinci 5 robotic surgical system and launching advanced robotic-assisted orthopedic surgery.
Sahyadri Hospitals delivered Q2 FY27 revenue of INR375 crores (13% sequential growth) with EBITDA rising 26% quarter-on-quarter to INR73 crores. Its EBITDA margin improved to 19.5% in Q2 from 17.5% in Q1, ahead of FY26’s average margin of 15.5%. Digital revenues formed 11% of Sahyadri's revenue in H1 FY27.
Highlights
- Q2 FY27 revenue at INR3,400 crores, up 37% year-on-year
- Q2 FY27 EBITDA reached INR882 crores, a 30% increase year-on-year
- Average admission occupancy rose to 70% in Q2 FY27 from 65% in Q1 FY27
- Digital revenue accounted for 23% of total revenue in H1 FY27
- Sahyadri Hospitals Q2 FY27 revenue grew 13% sequentially to INR375 crores
- Sahyadri EBITDA margin improved to 19.5% in Q2 FY27 from 17.5% in Q1 FY27
Key Data Snapshot
What happened
- Manipal Health Enterprises reported record revenue of INR3,400 crores in Q2 FY27, increasing 37% year-on-year.
- EBITDA grew 30% to INR882 crores, with margins excluding Sahyadri at 27%.
- Inpatient volumes rose 35%, outpatient volumes rose 27%, and average occupancy increased to 70% during the quarter.
Financial performance
- Total H1 FY27 revenue rose 38% year-on-year to INR6,490 crores with EBITDA at INR1,631 crores, up 28%.
- PAT for H1 FY27 was INR639 crores, representing a net margin of 10%.
- Digital health services contributed 23% of revenue in H1 FY27, comprising e-pharmacy, telehealth consultations, and AI-based chatbot interactions.
Operational performance
- Centers of excellence contributed 64.2% of revenues in H1 FY27, driven by oncology, neurology, and orthopedics.
- Recent technology investments include Da Vinci 5 robotic surgical system and robotic orthopedic surgery.
- Sahyadri Hospitals achieved 13% quarter-on-quarter revenue growth to INR375 crores in Q2 FY27 with EBITDA margin improving to 19.5%.
Highlights
- Q2 FY27 revenue at INR3,400 crores, up 37% year-on-year
- Q2 FY27 EBITDA reached INR882 crores, a 30% increase year-on-year
- Average admission occupancy rose to 70% in Q2 FY27 from 65% in Q1 FY27
- Digital revenue accounted for 23% of total revenue in H1 FY27
- Sahyadri Hospitals Q2 FY27 revenue grew 13% sequentially to INR375 crores
- Sahyadri EBITDA margin improved to 19.5% in Q2 FY27 from 17.5% in Q1 FY27
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Source Information
More News on Earnings Call Transcript
View allLatest corporate announcements and market updates in Earnings Call Transcript.
Associated Alcohols & Breweries Reports 7% Revenue Rise in Q2 FY27, Launches Premium Tequila Brand Arcana
Associated Alcohols & Breweries Limited reported a 7% year-on-year revenue growth to INR2,716 million for the quarter ended September 30, 2026, powered by 28% volume growth in its IMFL Proprietary spirits business and the launch of its premium Blanco tequila, Arcana, in Madhya Pradesh.
Read Full StoryEMS Limited Reports Rs. 160.89 Crores Revenue and Rs. 22.92 Crores Profit in Q2 FY27 with Rs. 3,152 Crores Order Book
EMS Limited posted its Q2 FY27 unaudited standalone financial results, reporting operating income of Rs. 160.89 crores and a profit after tax of Rs. 22.92 crores, supported by a robust order book totaling Rs. 3,152 crores including Rs. 900 crores of recent orders from key Jal boards across India.
Read Full StoryFineotex Chemical Limited Releases Audio Recording of Q2-H1 FY 2026-2027 Financial Performance Conference Call
Fineotex Chemical Limited has published the audio file of its investor and analyst conference call held on November 16, 2026, covering financial results for Q2 and H1 FY 2026-2027. The recording is accessible on the company’s website for interested parties.
Read Full Story